FOXP3 and gastric cancer: This diverse immune infiltrate, including regulatory T cells (FOXP3+), mirrors the immunosuppressive microenvironment of human gastric cancer and may influence therapeutic responses to immunotherapy (Hou et al., 2014; Saleh and Elkord, 2020; Yuan et al., 2011).